SCHEMBL15025465

SCHEMBL15025465

NN1CCC(N2Cc3c(Cl)cccc3NC2=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.44
▸ MMP13 P45452 1/20 0.44
▸ LMNA P02545 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41
▸ CTSS P25774 4/20 0.39
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ AADAT Q8N5Z0 1/20 0.38
▸ HTR5A P47898 2/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ HTR1D P28221 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ HTR7 P34969 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13801327 0.85 ACE (0.43) ACEMMP13LMNACYP1A2CYP3A4
SCHEMBL3963853 0.84 ACE (0.46) ACEMMP13LMNACYP1A2CYP3A4
SCHEMBL14410187 0.84 PARP1 (0.45) ACEMMP13LMNACYP1A2CYP3A4
SCHEMBL3959945 0.82 CHRM4 (0.55) CYP3A4CYP2D6CHRM4CHRM3
SCHEMBL27455061 0.79 CHRM2 (0.53) HTR2ACALCRLCHRM4RAMP1OPRM1
SCHEMBL5371647 0.75 CALCRL (0.44) ACEMMP13CALCRL
SCHEMBL2866213 0.72 MAPK1 (0.52) CTSSCDK5CDK5R1AADATHTR5A
SCHEMBL31184907 0.69 JAK2 (0.40) ACEMMP13CDK5CDK5R1CALCRL
SCHEMBL2878324 0.69 HTR2C (0.41) CTSSHTR2AHTR2C
SCHEMBL31184899 0.67 MALT1 (0.45) LMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788333-B1 1,2,4-TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INT (DE) 2016-03-23 — — EP disclosed
WO-2013083741-A1 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 — — WO disclosed
Send feedback